JP2009542228A5 - - Google Patents

Download PDF

Info

Publication number
JP2009542228A5
JP2009542228A5 JP2009518632A JP2009518632A JP2009542228A5 JP 2009542228 A5 JP2009542228 A5 JP 2009542228A5 JP 2009518632 A JP2009518632 A JP 2009518632A JP 2009518632 A JP2009518632 A JP 2009518632A JP 2009542228 A5 JP2009542228 A5 JP 2009542228A5
Authority
JP
Japan
Prior art keywords
sequence
recombinase
chimeric
site
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009518632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009542228A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/072869 external-priority patent/WO2008006028A2/en
Publication of JP2009542228A publication Critical patent/JP2009542228A/ja
Publication of JP2009542228A5 publication Critical patent/JP2009542228A5/ja
Withdrawn legal-status Critical Current

Links

JP2009518632A 2006-07-05 2007-07-05 定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ Withdrawn JP2009542228A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81890806P 2006-07-05 2006-07-05
PCT/US2007/072869 WO2008006028A2 (en) 2006-07-05 2007-07-05 Chimeric zinc finger recombinases optimized for catalysis by directed evolution

Publications (2)

Publication Number Publication Date
JP2009542228A JP2009542228A (ja) 2009-12-03
JP2009542228A5 true JP2009542228A5 (cg-RX-API-DMAC7.html) 2010-08-26

Family

ID=38895472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009518632A Withdrawn JP2009542228A (ja) 2006-07-05 2007-07-05 定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ

Country Status (8)

Country Link
US (1) US8685687B2 (cg-RX-API-DMAC7.html)
EP (1) EP2046806A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009542228A (cg-RX-API-DMAC7.html)
KR (1) KR20090031938A (cg-RX-API-DMAC7.html)
CN (1) CN101484462A (cg-RX-API-DMAC7.html)
AU (1) AU2007269048A1 (cg-RX-API-DMAC7.html)
CA (1) CA2667974A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008006028A2 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
JP5173838B2 (ja) 2006-02-13 2013-04-03 アレシア・バイオセラピューティクス・インコーポレーテッド 骨リモデリングのプロセスと関係があるポリヌクレオチドおよびポリペプチド配列
MY160435A (en) * 2008-06-12 2017-03-15 Univ Putra Malaysia A novel antiviral peptide against avian influenza virus h9n2
WO2010042894A1 (en) * 2008-10-09 2010-04-15 The Regents Of The University Of California NOVEL NUCLEIC ACID CONSTRUCTS CONTAINING ORTHOGONAL SITE SELECTIVE RECOMBINASES (OSSRs)
GB2467167B (en) * 2009-01-26 2013-09-11 Algentech Sas Gene targeting in plants
NZ598457A (en) 2009-08-03 2014-06-27 Recombinetics Inc Methods and compositions for targeted gene modification
WO2012170436A1 (en) 2011-06-06 2012-12-13 The Regents Of The University Of California Synthetic biology tools
US9738879B2 (en) 2012-04-27 2017-08-22 Duke University Genetic correction of mutated genes
EP2841572B1 (en) * 2012-04-27 2019-06-19 Duke University Genetic correction of mutated genes
AU2013293062A1 (en) 2012-07-19 2014-07-24 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
EP4148134A1 (en) * 2012-09-04 2023-03-15 The Scripps Research Institute Chimeric polypeptides having targeted binding specificity
US10793867B2 (en) * 2013-03-15 2020-10-06 Monsanto Technology, Llc Methods for targeted transgene-integration using custom site-specific DNA recombinases
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
WO2014197748A2 (en) 2013-06-05 2014-12-11 Duke University Rna-guided gene editing and gene regulation
DK3049973T3 (en) 2013-09-27 2018-10-22 Codexis Inc AUTOMATED SCREENING OF ENZYM VARIENTS
WO2015048573A1 (en) 2013-09-27 2015-04-02 Codexis, Inc. Structure based predictive modeling
JP6303195B2 (ja) * 2013-11-20 2018-04-04 国立研究開発法人産業技術総合研究所 細菌による機能的外来タンパク質の製造方法
JP2017506080A (ja) * 2014-02-21 2017-03-02 プレジデント アンド フェローズ オブ ハーバード カレッジ アロステリックタンパク質の新規設計
WO2016081924A1 (en) 2014-11-20 2016-05-26 Duke University Compositions, systems and methods for cell therapy
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
CN104789555A (zh) * 2015-04-29 2015-07-22 江南大学 一种基于合成单链dna文库进化基因表达调控元件的方法
EP3337895B1 (en) 2015-08-21 2026-03-25 Monsanto Technology LLC Enhanced recombination of genomic loci
KR20240132120A (ko) 2015-08-25 2024-09-02 듀크 유니버시티 Rna-가이드된 엔도뉴클레아제를 이용하는 게놈 조작에서 특이성을 개선하는 조성물 및 방법
WO2017066497A2 (en) 2015-10-13 2017-04-20 Duke University Genome engineering with type i crispr systems in eukaryotic cells
US12214054B2 (en) 2015-11-30 2025-02-04 Duke University Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use
CN106011162A (zh) * 2016-01-27 2016-10-12 浙江大学 大肠杆菌细胞内原位进化目标蛋白质的新方法
EP3443081A4 (en) 2016-04-13 2019-10-30 Duke University CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE
JP7490211B2 (ja) 2016-07-19 2024-05-27 デューク ユニバーシティ Cpf1に基づくゲノム編集の治療適用
CN117821509A (zh) 2017-04-03 2024-04-05 编码治疗公司 组织选择性转基因表达
CN118345115A (zh) 2017-12-01 2024-07-16 编码治疗公司 工程化的dna结合蛋白
US12509492B2 (en) 2018-01-19 2025-12-30 Duke University Genome engineering with CRISPR-Cas systems in eukaryotes
CN109979591B (zh) * 2019-03-12 2021-01-01 众安信息技术服务有限公司 一种基于图神经网络分析斑块进展因子的方法及装置
TWI887234B (zh) 2019-04-14 2025-06-21 美國公爵大學 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除
SG11202113048SA (en) * 2019-05-29 2021-12-30 Encoded Therapeutics Inc Compositions and methods for selective gene regulation
CN114729376A (zh) 2019-09-23 2022-07-08 欧米茄治疗公司 用于调节肝细胞核因子4α(HNF4α)基因表达的组合物和方法
CN110868598B (zh) * 2019-10-17 2021-06-22 上海交通大学 基于对抗生成网络的视频内容替换方法及系统
TW202132565A (zh) * 2019-11-01 2021-09-01 美商聖加莫治療股份有限公司 Gin重組酶變異體
KR20260044268A (ko) 2023-06-26 2026-04-01 유니버시티 오브 하와이 진화한 인테그라제 및 이를 이용한 게놈 편집 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303930A (zh) * 1999-10-27 2001-07-18 上海博容基因开发有限公司 一种新的多肽——锌指蛋白57和编码这种多肽的多核苷酸
GB0222229D0 (en) * 2002-09-25 2002-10-30 Univ Glasgow Mutant recombinases
EP1755640A4 (en) * 2004-04-30 2009-10-28 Poetic Genetics Llc HYBRID RECOMBINATIONS FOR GENOMIC MANIPULATION
US7470777B2 (en) * 2004-12-22 2008-12-30 Iowa State University Research Foundation, Inc. Compositions and methods related to modified retroviral vectors for restricted, site specific integration

Similar Documents

Publication Publication Date Title
JP7459174B2 (ja) 標的結合特異性を有するキメラポリペプチド
KR101817482B1 (ko) 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정
CA3009727A1 (en) Compositions and methods for the treatment of hemoglobinopathies
US7608434B2 (en) Mutated Tn5 transposase proteins and the use thereof
CN104080462B (zh) 用于修饰预定的靶核酸序列的组合物和方法
CA3131284C (en) Compositions for linking dna-binding domains and cleavage domains
AU740336B2 (en) Heteroduplex mutational vectors and use thereof in bacteria
WO2017215648A1 (zh) 基因敲除方法
WO2019239361A1 (en) Method for sequence insertion using crispr
US20250243512A1 (en) Serine recombinase systems for site-specific gene editing
JP2000287687A (ja) プラスミドベクター
CA3163087A1 (en) System and method for activating gene expression
KR102151064B1 (ko) 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법
Huang et al. Identification of a partial internal deletion in the RH locus causing the human erythrocyte D--phenotype [see comments]
KR20190122596A (ko) 염기 교정용 유전자 구조체, 이를 포함하는 벡터 및 이를 이용한 염기 교정 방법
WO1996040882A1 (en) Artificial restriction endonuclease
JP2022519308A (ja) その中の核酸分子を差次的にメチル化するように操作されたミニサークル産生細菌
JP2009537130A (ja) Mos−1トランスポゾンの高活性組換え誘導体の転移のためのシステム
JP5156953B2 (ja) 核酸切断剤
KR102567576B1 (ko) 표적 특이성이 향상된 신규한 Cas9 단백질 변이체 및 이의 용도
CN120092083A (zh) 包含Cas蛋白和细菌毒素的融合蛋白及其用途
Varani et al. Prokaryotic Transposable Elements
KR20190037167A (ko) 혈액응고인자 viii 유전자 역위 보정능의 유전자 가위 시스템으로 구성된 혈우병 치료용 조성물
CA2957441C (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
JPH09131181A (ja) 変異型dnaポリメラーゼ